Kratom Regulation Framework
The kratom industry exploits regulatory gaps to market opioid-acting substances as "natural supplements" while dismissing addiction stories as user failure. Virginia must close these loopholes with comprehensive regulation—or complete prohibition if proper safety measures cannot be achieved—while ensuring legitimate medical access under proper oversight.
End Kratom Addiction challenges the industry's "natural equals safe" marketing deception by demanding transparent regulation. With tens of thousands now in recovery from substances sold as herbal wellness products, Virginia cannot allow this regulatory charade to continue unchallenged.
Contact LawmakersOur Regulatory Framework
End Kratom Addiction challenges the industry's "natural equals safe" marketing deception by demanding transparent regulation. With tens of thousands now in recovery from substances sold as herbal wellness products, Virginia cannot allow this regulatory charade to continue unchallenged.
End "Supplement" Deception
Classify kratom compounds under appropriate medical frameworks, ending the industry's ability to market opioid-receptor-acting substances as dietary supplements to unsuspecting consumers.
Consumer Truth-in-Labeling
Mandate honest labeling about addiction potential and withdrawal severity, ending deceptive marketing that hides the medical reality of dependence behind wellness terminology.
Virginia Regulation Framework
Our policy framework confronts industry deception head-on: substances requiring medical detox programs cannot be legally marketed as wellness supplements sold alongside snack foods.
Medical Access Control
Establishes medical classification for mitragynine, 7-hydroxymitragynine, and synthetic variants, ending their mislabeling as food products while maintaining controlled therapeutic access.
Consumer Protection
Prohibits false "natural and safe" advertising while mandating clear warnings about physical dependence, severe withdrawal, and the medical intervention required for safe discontinuation.
Medical Evidence Drives Policy
Clinical data from Virginia's medical professionals exposes the gap between industry marketing claims and treatment realities, providing lawmakers irrefutable evidence for regulatory action.
Detox Crisis Scale
Some Virginia treatment facilities document that addiction medicine caseloads now consist primarily of patients withdrawing from substances marketed as wellness supplements.
Online Community Evidence
Digital recovery platforms reveal thousands sharing withdrawal testimonies that contradict industry safety claims, yet Virginia permits unrestricted retail distribution of these compounds.
Regulatory Solution
Honest regulation protects consumers from deceptive marketing while maintaining appropriate medical applications under professional supervision and informed consent protocols.
Regulatory Models
Other states demonstrate successful approaches to ending kratom's regulatory exemption while preserving legitimate therapeutic applications under proper medical oversight.